Protofibrils are transient structures observed during in vitro for
mation of
mature a
myloid fibrilsand have been i
mplicated as the toxic species responsible for cell dysfunction and neuronal loss inAlzhei
mer's disease (AD) and other protein aggregation diseases. To better understand the roles ofprotofibrils in a
myloid asse
mbly and Alzhei
mer's disease, we characterized secondary structural featuresof these heterogeneous and
metastable asse
mbly inter
mediates. We chro
matographically isolated differentsize populations of protofibrils fro
m a
myloid asse
mbly reactions of A
mages/gifchars/beta2.gif" BORDER=0 ALIGN="
middle">(1-40), both wild type and theArctic variant associated with early onset fa
milial AD, and exposed the
m to hydrogen-deuteriu
m exchangeanalysis
monitored by
mass spectro
metry (HX-MS). We show that HX-MS can distinguish a
mongunstructured
mono
mer, protofibrils, and fibrils by their different protection patterns. We find that about40% of the backbone a
mide hydrogens of A
mages/gifchars/beta2.gif" BORDER=0 ALIGN="
middle"> protofibrils are highly resistant to exchange with deuteriu
meven after 2 days of incubation in aqueous deuterated buffer, i
mplying a very stable, presu
mably H-bonded,core structure. This is in contrast to
mature a
myloid fibrils, whose equally stable structure protects about60% of the backbone a
mide hydrogens over the sa
me ti
me fra
me. We also find a surprising degree ofspecificity in a
myloid asse
mbly, in that wild type A
mages/gifchars/beta2.gif" BORDER=0 ALIGN="
middle"> is preferentially excluded fro
m both protofibrilsand fibrils grown fro
m an equi
molar
mixture of wild type and Arctic
mutant peptides. These and otherdata are interpreted and discussed in ter
ms of the role of protofibrils in fibril asse
mbly and in disease.